Dow Up1.06% Nasdaq Up1.00%

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM
4.81 Up 0.05(1.05%) 9:30AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development1,594  2,772  1,395  1,192  
Selling General and Administrative1,781  2,072  1,409  2,353  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (3,375) (4,844) (2,804) (3,545)
Income from Continuing Operations
Total Other Income/Expenses Net13  4  5  3  
Earnings Before Interest And Taxes(3,362)(4,840)(2,799)(3,542)
Interest Expense -   -   -   -  
Income Before Tax(3,362)(4,840)(2,799)(3,542)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(3,429)(5,110)(2,799)(3,542)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (3,429) (5,110) (2,799) (3,542)
Preferred Stock And Other Adjustments(302)(298)(312)(181)
Net Income Applicable To Common Shares (3,731) (5,408) (3,111) (3,723)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.